IRIS Accounts Production v23.3.1.45 09158639 director 1.4.22 31.3.23 31.3.23 false true false false true false Ordinary 0.10000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh091586392022-03-31091586392023-03-31091586392022-04-012023-03-31091586392021-03-31091586392021-04-012022-03-31091586392022-03-3109158639ns14:PoundSterlingns10:Original2022-04-012023-03-3109158639ns10:Originalns10:Director12022-04-012023-03-3109158639ns10:Original2022-04-012023-03-3109158639ns10:Original2023-03-3109158639ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3109158639ns10:Originalns10:SmallEntities2022-04-012023-03-3109158639ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3109158639ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3109158639ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3109158639ns10:Originalns10:FullAccounts2022-04-012023-03-3109158639ns10:Originalns10:OrdinaryShareClass12022-04-012023-03-3109158639ns10:Originalns10:RegisteredOffice2022-04-012023-03-3109158639ns10:Original2022-03-3109158639ns10:Originalns5:CurrentFinancialInstruments2023-03-3109158639ns10:Originalns5:CurrentFinancialInstruments2022-03-3109158639ns10:Originalns5:Non-currentFinancialInstruments2023-03-3109158639ns10:Originalns5:Non-currentFinancialInstruments2022-03-3109158639ns5:ShareCapitalns10:Original2023-03-3109158639ns5:ShareCapitalns10:Original2022-03-3109158639ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3109158639ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3109158639ns10:Original2021-04-012022-03-3109158639ns10:Originalns5:PlantMachinery2022-03-3109158639ns10:Originalns5:PlantMachinery2022-04-012023-03-3109158639ns10:Originalns5:PlantMachinery2023-03-3109158639ns10:Originalns5:PlantMachinery2022-03-3109158639ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3109158639ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3109158639ns10:Originalns10:OrdinaryShareClass12023-03-31
REGISTERED NUMBER: 09158639 (United Kingdom)















Unaudited Financial Statements for the Year Ended 31 March 2023

for

Immediate Medical Solutions Ltd

Immediate Medical Solutions Ltd (Registered number: 09158639)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Immediate Medical Solutions Ltd

Company Information
for the Year Ended 31 March 2023







DIRECTOR: Mrs F Rizvi





REGISTERED OFFICE: 18 Raven Road
London
E18 1HB





REGISTERED NUMBER: 09158639 (United Kingdom)





ACCOUNTANTS: Primera Accountants Limited
First Floor
Spitalfields House
Stirling Way
Borehamwood
Hertfordshire
WD6 2FX

Immediate Medical Solutions Ltd (Registered number: 09158639)

Statement of Financial Position
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 61,935 69,237

CURRENT ASSETS
Debtors 5 707,933 957,710
Cash at bank 70,926 25,007
778,859 982,717
CREDITORS
Amounts falling due within one year 6 550,523 869,689
NET CURRENT ASSETS 228,336 113,028
TOTAL ASSETS LESS CURRENT
LIABILITIES

290,271

182,265

CREDITORS
Amounts falling due after more than one
year

7

35,817

39,666
NET ASSETS 254,454 142,599

CAPITAL AND RESERVES
Called up share capital 8 1,000 1,000
Retained earnings 253,454 141,599
SHAREHOLDERS' FUNDS 254,454 142,599

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Immediate Medical Solutions Ltd (Registered number: 09158639)

Statement of Financial Position - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 9 December 2023 and were signed by:





Mrs F Rizvi - Director


Immediate Medical Solutions Ltd (Registered number: 09158639)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

Immediate Medical Solutions Ltd is a private company, limited by shares , registered in United Kingdom. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
In the application of the company's accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period or in the period of the revision and future periods where the revision affects both current and future periods.

There are no significant judgements or estimates involved in the preparation of the financial statements.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax. Revenue is recognised when services are rendered to the customers.

Tangible fixed assets
Property, plant and equipment are stated at cost less accumulated depreciation and accumulated impairment losses. Such cost includes costs directly attributable to making the assets capable of operating as intended.

The carrying value of tangible assets are reviewed for impairment when events or changes in circumstances indicate the carrying value may not be recoverable.

Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.

Plant and machinery - 10% on cost
Fixtures and fittings - 10% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


Immediate Medical Solutions Ltd (Registered number: 09158639)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Cash and cash equivalent
Cash and cash equivalents in the statement of financial position comprise cash at banks and in hand, short term deposits with an original maturity date of one month. Cash equivalents are defined as short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.

Immediate Medical Solutions Ltd (Registered number: 09158639)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

2. ACCOUNTING POLICIES - continued

Financial instruments
Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset , with the net amounts presented in the financial statements , when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities
Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 19 (2022 - 16 ) .

Immediate Medical Solutions Ltd (Registered number: 09158639)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2022 77,601
Additions 8,430
At 31 March 2023 86,031
DEPRECIATION
At 1 April 2022 8,364
Charge for year 15,732
At 31 March 2023 24,096
NET BOOK VALUE
At 31 March 2023 61,935
At 31 March 2022 69,237

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade debtors 675,436 947,153
Other debtors 32,497 10,557
707,933 957,710

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Bank loans and overdrafts 5,243 15,898
Trade creditors 6,331 380,756
Taxation and social security 134,509 101,274
Other creditors 404,440 371,761
550,523 869,689

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.23 31.3.22
£    £   
Bank loans 35,817 39,666

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 13,485 19,279

Immediate Medical Solutions Ltd (Registered number: 09158639)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.23 31.3.22
value: £    £   
10,000 Ordinary 0.1 1,000 1,000

9. RELATED PARTY DISCLOSURES

Included in the other creditors due within one year is an amount of £165,592 (2022: £181,757.00) due to the director of the company. The loan was interest free and repayable on demand.

10. ULTIMATE CONTROLLING PARTY

The controlling party is Mrs F Rizvi.